Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study
Sign Up to like & getrecommendations! Published in 2022 at "Multiple Sclerosis and Related Disorders"
DOI: 10.1016/j.msard.2022.103560
Abstract: Background Antibody responses to SARS-CoV-2 vaccination are impaired in people with multiple sclerosis (MS) under anti-CD20 therapies. It is however unclear, whether patients who received the basic immunization prior to anti-B cell medication start respond… read more here.
Keywords: vaccine cohort; cd20 vaccine; antibody; anti cd20 ... See more keywords